Projects per year
Personal profile
Courses
Seminar
Advanced Biochemistry
Group Discussion for Problem-Based Learning in Basic Medical Education
Advanced Biochemistry
Group Discussion for Problem-Based Learning in Basic Medical Education
Education
Ph.D., University of California,USA
B.S., Davis,Taiwan
, National Taiwan Normal University,
B.S., Davis,Taiwan
, National Taiwan Normal University,
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Keywords
- Molecular Oncology, Cell biology, Epigenetics、Gene Regulation, Cell Metabolism
Fingerprint
Dive into the research topics where Ling-Yu Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Epigenetic Regulation of Neuroendocrine Transdifferentiation via the Ar-Cxxc4-Tet2 Axis
Wang, L.-Y. (PI) & Hsu, H. C. (CoPI)
01/08/25 → 31/07/26
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Exploring the Intermediate State of Therapy-Induced Neuroendocrine Prostate Cancer through Dissecting the Ar Noncanonical Roles
Wang, L.-Y. (PI), Hsu, H. C. (CoPI) & Kung, H. J. (CoPI)
01/08/24 → 31/07/25
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Ar-V7 Associated Histone Modification and Metabolic Alterations in Enzalutamide Resistant Prostate Cancer
Wang, L.-Y. (PI)
01/08/22 → 31/07/23
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Ar-V7 Associated Histone Modification and Metabolic Alterations in Enzalutamide Resistant Prostate Cancer
Wang, L.-Y. (PI)
01/08/21 → 31/07/22
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Ar-V7 Associated Histone Modification and Metabolic Alterations in Enzalutamide Resistant Prostate Cancer
Wang, L.-Y. (PI)
01/08/20 → 31/07/21
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancer
Hung, C. L., Hsu, W. N., Wang, T. C., Chen, W. R., Chen, Y. T., Kuo, Z. K., Hu, T. L., Lin, Y. C., Yeh, H. H., Lin, H. C., Yu, C. J., Fu, C. W., Liu, H. H., Hsu, H. C., Lin, P. H., Pang, S. T., Lai, C. H. & Wang, L. Y., 01 2026, In: Neoplasia (United States). 71, p. 101253 101253.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
PROTACs as Therapeutic Modalities for Drug Discovery in Castration-Resistant Prostate Cancer
Wang, L. Y., Hung, C. L., Wang, T. C., Hsu, H. C., Kung, H. J. & Lin, K. H., 23 01 2025, In: Annual review of pharmacology and toxicology. 65, 1, p. 375-396 22 p.Research output: Contribution to journal › Review article › peer-review
Open Access12 Scopus citations -
Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studies
Tang, W. F., Tsai, H. P., Chin, Y. F., Tsai, S. K., Lin, C. C., Ngo, S. T., Liang, P. H., Jheng, J. R., Hsieh, C. F., Lee, J. C., Chang, Y. H., Chang, T. Y., Lin, C. Y., Lin, G. H., Cai, J. Y., Chen, Y. L., Chen, Y. S., Liu, P. C., Yang, C. M. & Shadbahr, T. & 9 others, , 08 2025, In: Biomedicine and Pharmacotherapy. 189, 118252.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
Tang, W. F., Chang, Y. H., Lin, C. C., Jheng, J. R., Hsieh, C. F., Chin, Y. F., Chang, T. Y., Lee, J. C., Liang, P. H., Lin, C. Y., Lin, G. H., Cai, J. Y., Chen, Y. L., Chen, Y. S., Tsai, S. K., Liu, P. C., Yang, C. M., Shadbahr, T., Tang, J. & Hsu, Y. L. & 9 others, , 03 04 2024, In: Antimicrobial Agents and Chemotherapy. 68, 4, p. e0095623Research output: Contribution to journal › Journal Article › peer-review
Open Access8 Scopus citations -
Selective p300 degradation via peptide PROTAC: a new therapeutic strategy for advanced prostate cancers
Wang, L. Y., 08 2024, In: EBioMedicine. 106, p. 105245 105245.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations